1887
Volume 2021, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: Abnormal invasive placentation leads to massive intraoperative hemorrhage and maternal morbidity. This study aimed to assess the impact of the preoperative use of internal iliac artery balloon occlusion (IIABO) catheters in patients who had a cesarean delivery (CD) for invasive placentation, commonly known as the placenta accreta spectrum.

Methods: This retrospective cohort study reviewed 67 pregnancies complicated by abnormal invasive placenta and confirmed intraoperatively. Preoperative planned placement of IIABO was performed in 33 women who underwent elective CD. Senior Obstetricians with the necessary expertise performed all CDs. The primary outcome measures were: intraoperative blood loss, blood transfusion requirement, duration of surgery and the need for hemostatic measures. Univariate comparison between the groups and regression analysis of the primary outcome and controlling for confounders, were performed.

Results: No statistically significant difference was observed between the groups with intraoperative hemorrhage volume of above 3000 mL (unadjusted odds ratio [OR] 0.94 [no-IIABO group as the reference];  = 0.895) and the median duration of surgery (median 107, interquartile range [IQR] 80–135 . median 96, IQR 75–121;  = 0.3508). More than 40% of the IIABO group required intraoperative transfusion of packed red blood cells above six units (14 [42.4%] . 10 [29.4%];  = 0.357]), and 30% required additional postoperative transfusion (10 [30.3%] . 8 [23.5%];  = 0.706]), although not statistically significant. Multivariate logistic regression analysis showed that the difference remained nonsignificant after covariate adjustment (adjusted OR 0.585,  = 0.456). Cesarean hysterectomy was performed in fewer cases (seven [21.1%]) in the IIABO group than in the no-IIABO group (10 [29.4%]), although this difference was not significant (unadjusted OR 0.65,  = 0.442).

Conclusions: The placement of IIABO catheters is an invasive procedure, which consumes time and resources. Its value as a means of reducing intraoperative blood loss or preserving the uterus in patients with abnormal placental adherence appears questionable. In this cohort study, there was no statistical difference in blood loss, and the need for other steps to control hemorrhage between women with and without IIABO catheters.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2021.8
2021-03-15
2021-06-21
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2021/1/qmj.2021.8.html?itemId=/content/journals/10.5339/qmj.2021.8&mimeType=html&fmt=ahah

References

  1. Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta 2012; 33:(4):244–251.
    [Google Scholar]
  2. Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018 Dec; 219:(6): B2-B16. doi: 10.1016/j.ajog.2018.09.042. PMID: 30471891.
    [Google Scholar]
  3. World Health Organization. WHO Recommendations for the prevention and treatment of postpartum hemorrhage. Geneva: World Health Organization, 2012.
    [Google Scholar]
  4. Rao KP, Belogolovkin V, Yankowitz J, Spinnato JA II. Abnormal placentation: evidence-based diagnosis and management of placenta praevia, placenta accreta, and vasa praevia. Obstet Gynecol Surv2012; 67:(8):503–519.
    [Google Scholar]
  5. Committee on Obstetric Practice. Committee opinion no. 529. Placenta accreta. Obstet Gynecol 2012; 120:(1):207–211.
    [Google Scholar]
  6. Ganguli S, Stecker MS, Pyne D, Baum RA, Fan CM. Uterine artery embolization in the treatment of postpartum uterine hemorrhage. J Vasc Interv Radiol 2011; 22:(2):169–176.
    [Google Scholar]
  7. Sentilhes L, Kayem G, Chandrahan E, Palacios-Jaraquemada J, Jauniaux E. FigO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynecol Obstet 2018; 140:(3):291–298.
    [Google Scholar]
  8. Royal College of Obstetricians and Gynaecologists Royal College of Midwives National Patient Safety Agency. Safer Practice in Intrapartum Care Project Care Bundles. Placenta praevia after previous lower-section caesarean segment care bundle (2010)RCOG, London. Pg 23-31.
    [Google Scholar]
  9. McGinnis JM, Simula NK, Joseph KS, Ubhi JS. Internal iliac artery balloon tamponade in placenta accreta: outcomes from the largest tertiary accreta referral centre in British Columbia. J Obstet Gynaecol Can2019; 41:(4):466–472.
    [Google Scholar]
  10. Fan Y, Gong X, Wang N, Mu K, Feng L, Qiao F, et al. A prospective observational study evaluating the efficacy of prophylactic internal iliac artery balloon catheterization in the management of placenta praevia–accreta: a STROBE compliant article. Medicine 2017; 96:(45):e8276.
    [Google Scholar]
  11. Feng S, Liao Z, Huang H. Effect of prophylactic placement of internal iliac artery balloon catheters on outcomes of women with placenta accreta: an impact study. Anaesthesia 2017; 72:(7):853–858.
    [Google Scholar]
  12. Bishop S, Butler K, Monaghan S, Chan K, Murphy G, Edozien L. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta accreta. Int J Obstet Anesth 2011; 20:(1):70–73.
    [Google Scholar]
  13. Yamada T, Hirahata E, Ihara N, Nishimura D, Inoue K, Kato J, et al. Cesarean hysterectomy in a hybrid operating room for placenta percreta: a report of three cases. JA Clin Rep 2019; 5:(1):1–4.
    [Google Scholar]
  14. Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG 2019; 126:(1):e1–e48.
    [Google Scholar]
  15. Shabana A, Fawzy M, Refaie W. Conservative management of placenta percreta: a stepwise approach. Arch Gynecol Obstet 2015; 291:(5):993–998.
    [Google Scholar]
  16. Marshall NE, Fu R, Guise JM. Impact of multiple caesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol 2011; 205:(3):262-e1.
    [Google Scholar]
  17. Cunningham KM, Anwar A, Lindow SW. The recurrence risk of placenta accreta following uterine conserving management. J Neonatal Perinatal Med 2015; 8:(4):293–296.
    [Google Scholar]
  18. D'Souza DL, Kingdom JC, Amsalem H, Beecroft JR, Windrim RC,Kachura JR. Conservative management of invasive placenta using combined prophylactic internal iliac artery balloon occlusion and immediate postoperative uterine artery embolization. Can Assoc Radiol J. 2015; 66:(2):179–184.
    [Google Scholar]
  19. Chodraui-Filho SF, Monsignore LM, Freitas RK, Nakiri GS, de Carvalho Cavalli R, Duarte G, Abud DG. Can the combination of internal iliac temporary occlusion and uterine artery embolization reduce bleeding and the need for intraoperative blood transfusion in cases of invasive placentation? Clinics (Sao Paulo). 2019; 74::e946. doi: 10.6061/clinics/2019/e946. Epub 2019 Jun 19. PMID: 31241664; PMCID: PMC6558998.
    [Google Scholar]
  20. Chen L, Wang X, Wang H, li Q, Shan N, Hongbo Q. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019; 19:(1):301–308.
    [Google Scholar]
  21. Chen T, Xu XQ, Shi HB, Yang ZQ, Zhou X, Pan Y. Conventional MRI features for predicting the clinical outcome of patients with invasive placenta. Diagn Interv Radiol 2017; 23:(3):173.
    [Google Scholar]
  22. Chen T, Xu XQ, Shi HB, Yang ZQ, Pan Y. Conventional MRI features for predicting the clinical outcome of patients with invasive placenta. Diagn Interv Radiol 2017; 23:(3):173–179.
    [Google Scholar]
  23. Hishikawa K, Koshiyama M, Ueda M, Yamaguchi A, Ukita S, Yagi H, Kakui K. Exchange of intraoperative balloon occlusion of the internal iliac artery for the common iliac artery during cesarean hysterectomy in a patient with placenta percreta. Am J Case Rep. 2013 Oct 11;:14:409-11. doi: 10.12659/AJCR.889449. PMID: 24147189; PMCID: PMC3797603.
    [Google Scholar]
  24. Li P, Liu X, Li X, Wei X, Liao J. Clinical outcomes and anesthetic management of pregnancies with placenta previa and suspicion for placenta accreta undergoing intraoperative abdominal aortic balloon occlusion during cesarean section. BMC Anesthesiol 2020; 20:(1):133.
    [Google Scholar]
  25. Cho YJ, Oh YT, Kim SY, Kim JY, Jung SY, Chon SJ, et al. The efficacy of pre-delivery prophylactic trans-catheter arterial balloon occlusion of bilateral internal iliac artery inpatients with suspected placental adhesion. Obstet Gynecol Sci 2017; 60:(1):18–25.
    [Google Scholar]
  26. Yu SCH, Cheng YKY, Tse WT, Sahota DS, Chung MY, Wong SSM, et al. Perioperative prophylactic internal iliac artery balloon occlusion in the prevention of postpartum hemorrhage in placenta previa: a randomized controlled trial. Am J Obstet Gynecol 2020; 223:(1):117–e1.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2021.8
Loading
/content/journals/10.5339/qmj.2021.8
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error